Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20190722044300N1Phase 3Completed
Phase 3, open-label trial of triamcinolone hexacetonide and acetaminophen in trigger finger (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Postoperative pain severity. Started Jun 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20190722044300N1.